← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lyra Therapeutics, Inc.
Watertown, MA
$4,784,935
Total funding
3
Grants
Funding over time
peak $1.4M · FY2013–18$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,784,935 · 3
By mechanism
R44$2,860,961 · 1
N44$1,526,022 · 1
N43$397,952 · 1
Investigators at Lyra Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel Bioabsorbable, Flexible Polymeric Stent for Pulmonary Artery Stenosis$989,446
R44 · FY2016 · HL
Novel Bioabsorbable, Flexible Polymeric Stent for Pulmonary Artery Stenosis$945,564
R44 · FY2017 · HL
Novel Bioabsorbable, Flexible Polymeric Stent for Pulmonary Artery Stenosis$925,951
R44 · FY2018 · HL
IGF::OT::IGF SBIR Topic 079 Phase I- Bioabsorbable Stents for Pediatric Pulmonary$813,515
N01 · FY2014 · HL
IGF::OT::IGF SBIR Topic 079 Phase I- Bioabsorbable Stents for Pediatric Pulmonary$512,507
N44 · FY2015 · HL
IGF::OT::IGF SBIR TOPIC 096:THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA IN NEONATES CAN# 16-8470256$397,952
N43 · FY2016 · HL
IGF::OT::IGF SBIR Topic 079 Phase I- Bioabsorbable Stents for Pediatric Pulmonary$200,000
N01 · FY2013 · HL